Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis
Li, K.H.C., Ho, J.C.S., Recaldin, B., Gong, M., Ho, J., Li, G., Liu, T., Wu, W.K.K., Wong, M.C.S., Xia, Y., Dong, M., Tse, G.
Published in Transplantation proceedings (01.12.2018)
Published in Transplantation proceedings (01.12.2018)
Get full text
Journal Article
WITHDRAWN: Acute Cellular Rejection and Infection Rates in Alemtuzumab vs Traditional Induction Therapy Agents for Lung and Heart Transplantation: A Systematic Review and Meta-analysis
Li, K H C, Ho, J C S, Recaldin, B, Gong, M, Ho, J, Li, G, Liu, T, Wu, W K K, Wong, M C S, Xia, Y, Dong, M, Tse, G
Published in Transplantation proceedings (01.12.2018)
Published in Transplantation proceedings (01.12.2018)
Get full text
Journal Article
Abstract P4-13-06: Real-world experience using exemestane and everolimus in patients with hormone receptor positive/HER2 negative breast cancer with and without prior CDK4/6 inhibitor exposure
Lupichuk, SM, Recaldin, B, Nixon, NA, Mututino, A, Joy, AA
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article